The cost of catheter-related bloodstream infections: Implications for the value of prevention

Journal of Infusion Nursing

Volumn 34, Issue 5, 2011, Pages 309-313

  Hollenbeak, Christopher S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; PLACEBO;

BLOODSTREAM INFECTION; CATHETER INFECTION; CLINICAL DECISION MAKING; DISEASE SEVERITY; HOSPITAL; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); MYCOSIS; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW;

ADULT; CATHETERS, INDWELLING; HEALTH CARE COSTS; HUMANS; INTENSIVE CARE UNITS; SEPSIS; UNITED STATES;

EID: 80052992422     PISSN: 15331458     EISSN: 15390667     Source Type: Journal    
DOI: 10.1097/NAN.0b013e3182285e43     Document Type: Review

References (14)

1. Al-Rawajfah OM, Stetzer F, Beauchamp Hewitt J. Incidence of and risk factors for nosocomial bloodstream infections in adults in the United States, 2003. Infect Control Hosp Epidemiol. 2009;30(11):1036-1044.
2. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271(20):1598-1601.
3. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51(RR-10):1-29.
4. Tompkins RG, Burke JF. Infections of Burn Wounds. 3rd ed. Boston, MA: Little, Brown; 1992.
5. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med. 2006;34(8):2084-2089. (Pubitemid 44305609)
6. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA. 2009;301(7):727-736.
7. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309-317. (Pubitemid 39050477)
8. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999;160(3):976-981. (Pubitemid 29442039)
9. Shannon RP, Patel B, Cummins D, Shannon AH, Ganguli G, Lu Y. Economics of central line-associated bloodstream infections. Am J Med Qual. 2006;21(6) (suppl):7S-16S.
10. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix C W, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001;136(2):229-234. (Pubitemid 32143849)
11. Elward AM, Hollenbeak CS, Warren DK, Fraser VJ. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics. 2005;115(4):868-872.
12. Kilgore M, Brossette S. Cost of bloodstream infections. Am J Infect Control. 2008;36(10):S172 e171-S172 e173.
13. CMS proposes additions to list of hospital-acquired conditions for fiscal year 2009 [news release]. Baltimore, MD: Centers for Medicare & Medicaid Services; April 14, 2008. http://www.cms.hhs.gov/apps/media/press/factsheet.asp? Counter=3042. Accessed March 1, 2010.
14. US Department of Health and Human Services. Part II: Department of Health and Human Services: Centers for Medicare & Medicaid Services. 42 CFR. Fed Regist. 2008;73(161):48434-49083.